Aaron J - Search Results

1

Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions.

Hong DS, Banerji U, Tavana B, George GC, Aaron J, Kurzrock R. Hong DS, et al. Among authors: aaron j. Cancer Treat Rev. 2013 Jun;39(4):375-87. doi: 10.1016/j.ctrv.2012.10.001. Epub 2012 Nov 28. Cancer Treat Rev. 2013. PMID: 23199899 Review.

2

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors.

Naing A, Reuben JM, Camacho LH, Gao H, Lee BN, Cohen EN, Verschraegen C, Stephen S, Aaron J, Hong D, Wheler J, Kurzrock R. Naing A, et al. Among authors: aaron j. J Cancer. 2011 Feb 10;2:81-9. doi: 10.7150/jca.2.81. J Cancer. 2011. PMID: 21326629 Free PMC article.

3

Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus.

Piha-Paul SA, Shin SJ, Vats T, Guha-Thakurta N, Aaron J, Rytting M, Kleinerman E, Kurzrock R. Piha-Paul SA, et al. Among authors: aaron j. Anticancer Res. 2014 Apr;34(4):1939-45. Anticancer Res. 2014. PMID: 24692729 Free PMC article. Clinical Trial.

4

Juice plus or toxicity plus.

Naing A, Aaron J, Kurzrock R. Naing A, et al. Among authors: aaron j. Am J Med. 2010 Jan;123(1):e1-2. doi: 10.1016/j.amjmed.2009.06.025. Am J Med. 2010. PMID: 20102976 No abstract available.

5

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K. McDonald JM, et al. Among authors: aaron j. Cancer. 2005 Oct 1;104(7):1468-77. doi: 10.1002/cncr.21338. Cancer. 2005. PMID: 16088966 Free article.

6

Patient-physician communication in oncology: past, present, and future.

Baile WF, Aaron J. Baile WF, et al. Among authors: aaron j. Curr Opin Oncol. 2005 Jul;17(4):331-5. doi: 10.1097/01.cco.0000167738.49325.2c. Curr Opin Oncol. 2005. PMID: 15933462 Review.

7

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K. Colman H, et al. Among authors: aaron j. Am J Surg Pathol. 2006 May;30(5):657-64. doi: 10.1097/01.pas.0000202048.28203.25. Am J Surg Pathol. 2006. PMID: 16699322

8

Silence is not golden: communicating with children dying from cancer.

Beale EA, Baile WF, Aaron J. Beale EA, et al. Among authors: aaron j. J Clin Oncol. 2005 May 20;23(15):3629-31. doi: 10.1200/JCO.2005.11.015. J Clin Oncol. 2005. PMID: 15908676 Review. No abstract available.

9

Breast cancer: unique communication challenges and strategies to address them.

Parker PA, Aaron J, Baile WF. Parker PA, et al. Among authors: aaron j. Breast J. 2009 Jan-Feb;15(1):69-75. doi: 10.1111/j.1524-4741.2008.00673.x. Epub 2008 Dec 12. Breast J. 2009. PMID: 19120379 Review.

10

Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry.

Rosanio S, Tocchi M, Cutler D, Uretsky BF, Stouffer GA, deFilippi CR, MacInerney EJ, Runge SR, Aaron J, Otero J, Garg S, Runge MS. Rosanio S, et al. Among authors: aaron j. JAMA. 1999 Jul 14;282(2):145-52. doi: 10.1001/jama.282.2.145. JAMA. 1999. PMID: 10411195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page